1 |
Crosbie EJ, Einstein MH, Franceschi S, et al. Human papillomavirus and cervical cancer[J]. Lancet, 2013,382(9895):889-899.
|
2 |
de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis[J]. Lancet Oncol, 2012,13(6):607-615.
|
3 |
田欣欣,王睿,姜玲波,等. 山东地区1225例男性尖锐湿疣患者HPV感染亚型分析[J]. 中国男科学杂志, 2016,30(7):41-45.
|
4 |
Huh WK, Ault KA, Chelmow D, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance[J]. Obstet Gynecol, 2015,125(2):330-337.
|
5 |
Wang R, Guo XL, Wisman GB, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China[J]. BMC Infect Dis, 2015,15:257.
|
6 |
de Sanjose S, Diaz M, Castellsague X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis[J]. Lancet Infect Dis, 2007,7(7):453-459.
|
7 |
Castle PE, Stoler MH, Wright TC Jr, et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study[J]. Lancet Oncol, 2011,12(9):880-890.
|
8 |
Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases[J]. Vaccine, 2012,30 Suppl 5:F12-23.
|
9 |
Li J, Huang R, Schmidt JE, et al. Epidemiological features of human papillomavirus (HPV) infection among women living in Mainland China[J]. Asian Pac J Cancer Prev, 2013, 14(7):4015-4023.
|
10 |
杨慧丽. 济南市正常女性、宫颈癌前病变及宫颈癌患者中HPV感染型别分布的研究[D]. 山东大学, 2014.
|
11 |
刘敏,王传新,邓小梅,等. 应用液相基因芯片技术筛查山东地区高危人群人乳头瘤病毒基因型[J]. 中华流行病学杂志, 2007,28(5):487-490.
|
12 |
Bi Q, Zhang L, Zhao Z, et al. Human papillomavirus prevalence and genotypes distribution among female outpatients in Qingdao, East China[J]. J Med Virol, 2015,87(12):2114-2121.
|
13 |
张丽冉,王睿,王新国,等. 山东省女性高危型人乳头状瘤病毒感染的检测分析[J]. 中国癌症防治杂志, 2016,8(1):38-43.
|
14 |
王睿,卜范峰,田欣欣,等. 山东地区女性人乳头瘤病毒感染亚型、多重感染情况及年龄分布差异[J]. 中国生物制品学杂志, 2016,29(1):57-60.
|
15 |
Zeng Z, Austin RM, He X, et al. Prevalence of high-risk human papillomavirus infection in China: analysis of 671,163 human papillomavirus test results from China′s Largest College of American Pathologists-Certified Laboratory[J]. Am J Clin Pathol, 2016,145(5):622-625.
|
16 |
Zeng Z, Yang H, Li Z, et al. Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV Genotyping Results from China′s Largest CAP Certified Laboratory[J]. J Cancer, 2016,7(9):1037-1043.
|
17 |
Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group[J]. J Natl Cancer Inst, 1995,87(11):796-802.
|
18 |
Xie F, Han M, Zhang L, et al. Prior Pap test and high risk HPV detection in Chinese women with CIN2/3 [J]. J Low Genit Tract Dis, 2017,21(2):S33-34.
|
19 |
Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women[J]. N Engl J Med, 2015,372(8):711-723.
|